Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lobular Carcinoma in Situ (LCIS)”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Not applicableStudy completedNCT00898508
What this trial is testing

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

Who this might be right for
Breast Cancer
City of Hope Medical Center 563
Testing effectiveness (Phase 2)UnknownNCT01641406
What this trial is testing

"Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"

Who this might be right for
Infiltrating Duct and Lobular Carcinoma In SituInvasive Lobular Breast CarcinomaInflammatory Breast Carcinoma
Auxilio Mutuo Cancer Center 60
Early research (Phase 1)Study completedNCT03323658
What this trial is testing

Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer

Who this might be right for
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Ductal Carcinoma In Situ+2 more
National Cancer Institute (NCI) 24
Not applicableUnknownNCT00536718
What this trial is testing

Genetics of Women With Lobular Carcinoma in Situ of the Breast

Who this might be right for
Breast Cancer
National Cancer Research Network 3,000
Early research (Phase 1)Not Yet RecruitingNCT07408856
What this trial is testing

CAN1012 in Pre-Malignant DCIS and LCIS

Who this might be right for
Ductal Carcinoma in SituLobular Carcinoma in Situ
Providence Health & Services 24
Not applicableWithdrawnNCT00041353
What this trial is testing

Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer

Who this might be right for
Breast Cancer
Fox Chase Cancer Center
Not applicableStudy completedNCT02216136
What this trial is testing

Tumor: Breast Ratio Study

Who this might be right for
Breast CancerLCISDCIS
Washington University School of Medicine 162
Testing effectiveness (Phase 2)Study completedNCT01082211
What this trial is testing

Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery

Who this might be right for
Breast Cancer
Radiation Therapy Oncology Group 65
Not applicableWithdrawnNCT00083044
What this trial is testing

Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy

Who this might be right for
Breast Cancer
Northwestern University
Large-scale testing (Phase 3)Active Not RecruitingNCT01905046
What this trial is testing

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaBRCA1 Mutation CarrierBRCA2 Mutation Carrier+2 more
Alliance for Clinical Trials in Oncology 86
Large-scale testing (Phase 3)Study completedNCT00004205
What this trial is testing

Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 8,028
Early research (Phase 1)Active Not RecruitingNCT03317405
What this trial is testing

Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery

Who this might be right for
Breast Ductal Carcinoma In SituBreast Lobular Carcinoma In SituStage 0 Breast Cancer AJCC v6 and v7+10 more
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Ended earlyNCT03979508
What this trial is testing

Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+15 more
Mayo Clinic 26
Not applicableStudy completedNCT01723943
What this trial is testing

Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients

Who this might be right for
Anxiety DisorderDepressionDuctal Breast Carcinoma in Situ+8 more
University of Washington 108
Not applicableStudy completedNCT00146536
What this trial is testing

Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy

Who this might be right for
Breast Neoplasms
Dana-Farber Cancer Institute 78
Not applicableStudy completedNCT00620087
What this trial is testing

Molecular Breast Imaging in Women With Atypia and LCIS

Who this might be right for
Atypical Lobular HyperplasiaAtypical Ductal HyperplasiaLobular Carcinoma in Situ
Mayo Clinic 66
Not applicableActive Not RecruitingNCT04496739
What this trial is testing

Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)

Who this might be right for
Atypical Hyperplasia of the BreastLobular Breast Carcinoma In SituPleomorphic Lobular Breast Carcinoma In Situ
SWOG Cancer Research Network 412
Not applicableStudy completedNCT01874184
What this trial is testing

Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaAtypical Lobular Breast HyperplasiaBRCA1 Mutation Carrier+3 more
University of Washington 17
Not applicableStudy completedNCT04225585
What this trial is testing

Well-Being After Breast Cancer Surgery

Who this might be right for
Coping Skills Training for Persistent Post-Surgical PainGeneral Health Education
Duke University 316
Early research (Phase 1)Study completedNCT01372644
What this trial is testing

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial

Who this might be right for
Atypical Ductal Breast HyperplasiaLobular Carcinoma in Situ (LCIS)Atypical Lobular Hyperplasia (ALH) of Breast
NYU Langone Health 15
Load More Results